Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2011-005127-40 | EudraCT Number |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
People with diabetes can, over time develop nerve damage throughout the body with symptoms such as pain, tingling, or numbness (loss of feeling) in the hands, arms, feet and legs.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| ABT-639 | Experimental |
| |
| Placebo | Placebo Comparator |
| |
| Lidocaine | Active Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| ABT-639 | Drug | two 50 mg oral capsules |
| |
| Placebo |
| Measure | Description | Time Frame |
|---|---|---|
| Spontaneous activity in peripheral c-nociceptors | Spontaneous activity in peripheral c-nociceptor measured through microneurography | 10 minute intervals over 180 minutes |
| Measure | Description | Time Frame |
|---|---|---|
| Pain intensity measurements | Pain intensity reported on a numerical rating scale | hourly for 4 hours |
Not provided
Inclusion Criteria
Exclusion Criteria
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Rita Jain, MD | AbbVie | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Site Reference ID/Investigator# 68882 | London | SE1 3XF | United Kingdom |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 26035253 | Derived | Serra J, Duan WR, Locke C, Sola R, Liu W, Nothaft W. Effects of a T-type calcium channel blocker, ABT-639, on spontaneous activity in C-nociceptors in patients with painful diabetic neuropathy: a randomized controlled trial. Pain. 2015 Nov;156(11):2175-2183. doi: 10.1097/j.pain.0000000000000249. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Drug |
2 placebo capsules |
|
| Lidocaine | Drug | 3mg/kg infusion over 30 minutes |
|
| ID | Term |
|---|---|
| C000589982 | 4-chloro-2-fluoro-N-(2-fluorophenyl)-5-(hexahydropyrrolo(1,2-a)pyrazin-2(1H)-ylcarbonyl)benzenesulfonamide |
| D008012 | Lidocaine |
| ID | Term |
|---|---|
| D000083 | Acetanilides |
| D000813 | Anilides |
| D000577 | Amides |
| D009930 | Organic Chemicals |
| D000814 | Aniline Compounds |
| D000588 | Amines |
Not provided
Not provided